The critical role of B7-1 as a co-stimulatory factor in generating an antitumor immune response is suggested by numerous in vivo experimental models, including those involving melanomas, adenocarcinomas, and gliomas [17,24,25,26,27]. The gene discussed is CD80; the disease is melanoma.